Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.9, 1999-09, pp. : 1385-1396

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Tolerability of First-Generation Selective Estrogen Receptor Modulators in Breast Cancer Treatment and Prevention

By Curtis M.G.

Drug Safety, Vol. 24, Iss. 14, 2001-01 ,pp. : 1039-1053

Adis International

Access to resources Recommend Favorite

Selective Estrogen Receptor Modulators and Aromatase Inhibitors for Breast Cancer Chemoprevention

Current Drug Targets, Vol. 12, Iss. 13, 2011-12 ,pp. : 1874-1887

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Selective Estrogen Receptor Modulators for Breast Cancer

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-09 ,pp. : 1191-1201

Bentham Science Publishers

Access to resources Recommend Favorite

The First Organometallic Selective Estrogen Receptor Modulators (SERMs) and Their Relevance to Breast Cancer

Current Medicinal Chemistry, Vol. 11, Iss. 18, 2004-09 ,pp. : 2505-2517

Bentham Science Publishers

Access to resources Recommend Favorite

Selective androgen receptor modulators

By Chengalvala Murty Oh Thomas Roy Arun K

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 59-66

Informa Healthcare

Access to resources Recommend Favorite